Trauma: Fasciotomy, laporotomy, gunshot wound, knife wound, electrical and chemical burn, compound fracture, loss of tissue, abdominal trauma (sepsis / abdominal comp. syndrome).

General: Abdominal complications (sepsis/abdominal comp. syndrome), removal of gangrenous tissue, removal of infectious tissue, various hernia closures, other delayed primary and secondary closure, removal of cancerous lesions and tumor growth sites.

Cardiothoracic: Sternotomy wound closure, other delayed primary and secondary closures, use as a "bolster” for chest closures to prevent re-opening of wound.

Cardiovascular: Delayed primary and secondary closures, use as a "bolster" to prevent re-opening of wound, various complicated hernia closures.

Chronic Wounds: Decubitus ulcers, and chronic wound in cases where viable and vascular tissue can be approximated through tensioning. Following removal of infected tissue the STAR can bring opposing margins of viable tissue to linear closure. Smaller areas may also be excised and reduced to linear closure where surrounding tissue is viable.

Plastics & Reconstructive: Removal of tissue, reduction of skin graft sites to linear closure, removal of birthmark and lesion sites, generation of excess skin for flap, use as bolster to prevent re-opening..

The S.T.A.R.™ device is shipped as a single use sterile product in a package with 6 units per box. The container is designed to fit exactly into a standard suture rack. The product is manufactured and sterile packaged by Genzyme Corp. of MA.